Synonyms: | |
Status: | Phase 3 |
Entry Type: | Antibody |
Molecule Category: | UNKNOWN |
UNII: | Q16CT95N25 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Carcinoma, Non-Small-Cell Lung | 3 | D002289 | ClinicalTrials |
Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
Carcinoma, Hepatocellular | 2 | D006528 | ClinicalTrials |
Carcinoma | 2 | D002277 | ClinicalTrials |
Glioblastoma | 2 | D005909 | ClinicalTrials |
Triple Negative Breast Neoplasms | 2 | D064726 | ClinicalTrials |
Carcinoma, Squamous Cell | 2 | D002294 | ClinicalTrials |
Breast Neoplasms | 2 | D001943 | ClinicalTrials |
Hepatitis C | 1 | D006526 | ClinicalTrials |
Neoplasms | 1 | D009369 | ClinicalTrials |
Melanoma | 1 | D008545 | ClinicalTrials |
Breast Neoplasms, Male | 1 | D018567 | ClinicalTrials |
Rectal Neoplasms | 1 | D012004 | ClinicalTrials |
Prostatic Neoplasms | 1 | D011471 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 648904-28-3 |
ChEMBL | CHEMBL1742989 |
FDA SRS | Q16CT95N25 |
Guide to Pharmacology | 8002 |